Introduction: Propofol and Ephedrine are commonly used during anesthesia maintenance, the former as a hypnotic agent and the later as a vasopressor. The addition of propofol to ephedrine or administration of ephedrine before propofol injection is useful for decreasing or preventing propofol related hemodynamic changes and vascular pain. This in vitro study evaluated the antibacterial effect on common hospital-acquired infection pathogens of ephedrine alone or combined with propofol.
Introduction
Propofol a commonly used hypnotic agent for the induction and maintenance of anesthesia is known to be a microbial growth-promoting agent that is prone to contamination, due to its lipid emulsion structure.
1,2 Despite awareness of the potential of contaminated propofol, sepsis and endotoxemia are still observed, sometimes even causing mortality.
3---5 Several agents have been used in combination with propofol to decrease its risk of contamination, including lidocaine that is also helpful in reducing the pain observed during administration. 2,6---8 Propofol is, of course, not the only source of bacterial contamination in operating rooms and intensive care units, and several medications and devices can lead to the complications of bacterial contamination, including sepsis.
Ephedrine is a commonly used vasopressor agent that has been used for several purposes in anesthesia practices. 9, 10 Studies have demonstrated that the addition of propofol as an admixture to ephedrine or administration of ephedrine before propofol injection is useful for decreasing or preventing propofol related hemodynamic changes and propofol related vascular pain.
11---13 A recently published study reported that ephedrine had an antimicrobial effect on Escherichia coli at certain concentrations.
14 We are unaware of any similar studies.
This in vitro study was performed to evaluate the antibacterial effect on common hospital-acquired infection pathogens of ephedrine alone or combined with propofol.
Material and method

Drugs and microorganisms
Ephedrine (Efedrin Hidroklorür ampul 0.05 g mL −1 , Biosel, Turkiye) and 1% propofol (Propofol 1% Fresenius, Turkiye) was used in this study. The study was designed with two stages. In the first stage, the Minimum Inhibitory Concentrations (MIC) of ephedrine and propofol separately and combined were determined using the broth microdilution method according to the procedures outlined by the Clinical and Laboratory Standards Institute (CLSI). 15 In the second stage, the effect on growth rate of organisms found to be affected by these drugs was measured. Staphylococcus aureus ATCC 25923, E. coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, Enterococcus faecium RSKK 01.016 and a clinical isolate of a multidrug resistant Acinetobacter spp. were used as control microorganisms. These strains of bacteria were obtained from American Type Culture Collection, USA (ATCC) and Refik Saydam National Type Culture, Collection, Turkey (RSKK).
Determination of MIC
Step 1: Preparation of drug mixtures: Aseptic drug mixtures for Ephedrine (E), Propofol (P) and mixture of Ephedrine and Propofol (E + P) were prepared separately in 0.9% sterile physiologic saline with final concentrations of 512 g mL −1 , 256 g mL −1 , 128 g mL −1 , 64 g mL −1 ,
